Hermetica Superfood Encyclopedia
The Short Answer
Fagraea berteroana belongs to the family Gentianaceae and is expected to contain iridoid glycosides, secoiridoids, and phenolic compounds consistent with other genera in this family, which exert anti-inflammatory and antimicrobial effects through inhibition of NF-κB signaling and cyclooxygenase enzymes. Systematic phytochemical and clinical characterization of this species remains extremely limited, with documented use confined largely to ethnobotanical records describing topical bark preparations for wound healing in Tongan traditional medicine.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordLupe Fagraea berteroana benefits
Lupe — botanical close-up
Health Benefits
**Wound Healing Support**
Bark preparations have been applied topically in Tongan ethnomedicine to accelerate wound closure, a property likely attributable to astringent tannins and antimicrobial iridoids that reduce microbial colonization and support tissue repair.
**Antimicrobial Activity**
Related Fagraea and Gentianaceae species contain secoiridoids such as gentiopicroside and sweroside, which demonstrate inhibitory activity against gram-positive and gram-negative bacteria, suggesting a plausible mechanism for the bark's traditional wound antiseptic use.
**Anti-inflammatory Effects**
Iridoid glycosides characteristic of the Gentianaceae family modulate pro-inflammatory cytokine production, including TNF-α and IL-6, by suppressing NF-κB nuclear translocation, which may reduce localized inflammation at wound sites.
**Antioxidant Capacity**
Polyphenolic constituents, including flavonoids and hydroxycinnamic acid derivatives common in tropical Gentianaceae members, scavenge reactive oxygen species and may protect healing tissue from oxidative damage.
**Analgesic Potential**
Ethnobotanical accounts from Pacific Island healers describe bark poultices as having pain-relieving properties, consistent with iridoid-mediated inhibition of prostaglandin synthesis observed in pharmacological studies of related genera.
**Antipyretic Use**
Traditional Pacific Island medicine systems have employed related Fagraea species as febrifuges, with bitter secoiridoid compounds implicated in modulating hypothalamic temperature regulation pathways.
**Liver-Protective Properties**
Iridoids from Gentianaceae family members have demonstrated hepatoprotective activity in animal models by reducing malondialdehyde levels and restoring glutathione peroxidase activity, a property plausibly shared by Fagraea berteroana pending direct investigation.
Origin & History
Natural habitat
Fagraea berteroana is a tropical tree native to the Pacific Islands, including Tonga, Samoa, Fiji, and surrounding archipelagos, where it grows in coastal forests, secondary vegetation, and disturbed habitats at low to mid elevations. The tree thrives in humid, tropical climates with well-drained soils and is commonly found growing near village settlements, suggesting a long history of human cultivation and selection for medicinal use. In Tonga it is known as 'lupe,' a name shared with the Samoan tradition, and the tree is valued both for its timber and its bark, which is harvested by local healers for topical wound applications.
“Fagraea berteroana occupies a meaningful place in the traditional healing repertoire of Polynesian and Melanesian cultures, particularly in Tonga and Samoa, where healers known as 'tofā' or 'faito'o' incorporate the bark into wound-care protocols that have been transmitted orally across generations. The tree's common name 'lupe' in Tongan also carries cultural resonance as the word for the Pacific pigeon (Ducula pacifica), suggesting a deep integration of the plant into Pacific cosmological and linguistic traditions beyond purely medicinal contexts. Whistler's landmark 1992 ethnobotanical survey of traditional plant use in the Pacific documented Fagraea species as among the plants employed for skin conditions and wound management across multiple island groups, representing one of the few systematic records of this use. The medicinal knowledge surrounding lupe reflects broader Pacific Island healing philosophies in which the forest canopy is seen as a living pharmacy, with bark preparations considered particularly potent due to the protective and boundary-defining role bark plays in the life of the tree.”Traditional Medicine
Scientific Research
Peer-reviewed phytochemical or pharmacological studies specifically investigating Fagraea berteroana are extremely scarce in the indexed scientific literature as of the current date, and no controlled clinical trials have been identified for this species. Ethnobotanical surveys of Tongan and Samoan traditional medicine, including work by researchers such as Whistler (1992) documenting Pacific Island medicinal plants, provide the strongest documented evidence base, cataloguing the bark's wound-healing application but not quantifying efficacy outcomes. Some phytochemical work exists on the broader Fagraea genus, including Fagraea ceilanica and Fagraea fragrans, which have yielded iridoids, bisindole alkaloids, and triterpenes, lending chemical plausibility to related bioactivity in F. berteroana. The overall evidence base is best characterized as ethnobotanical with minimal preclinical support; rigorous pharmacognosic characterization and safety evaluation of this species represent a clear gap in the literature.
Preparation & Dosage
Traditional preparation
**Traditional Bark Decoction (Topical)**
Bark is scraped or pounded, boiled in water, and the cooled decoction is applied directly to wounds using cloth or leaf wrappings; no standardized concentration or volume has been established.
**Bark Poultice**
Fresh or dried bark is macerated and applied directly to skin lacerations, ulcers, or infected wounds; frequency of application is guided by healer tradition rather than clinical protocol.
**Internal Infusion (Reported)**
Some Pacific Island ethnobotanical records note oral infusions of bark or leaves for fever management, though precise preparation ratios and volumes are not documented in the scientific literature.
**Standardized Supplement Forms**
No commercially standardized supplement forms (capsule, tincture, or extract) of Fagraea berteroana are currently available; standardization percentages for iridoids or other markers have not been established.
**Dosage Note**
In the complete absence of clinical trial data, no safe or effective oral or topical dose can be recommended; use should follow guidance from experienced traditional practitioners within the cultural context of Pacific Island medicine.
Nutritional Profile
No systematic nutritional analysis of Fagraea berteroana bark, leaves, or other plant parts has been published in the peer-reviewed literature. Based on the phytochemical profile of closely related Gentianaceae members, the bark is expected to contain bitter secoiridoid glycosides (potentially including compounds analogous to gentiopicroside and swertiamarin), condensed tannins contributing astringency, flavonoid glycosides providing antioxidant capacity, and triterpenoids including oleanolic and ursolic acid derivatives. The leaves may contain chlorogenic acid, luteolin glycosides, and quercetin derivatives typical of tropical Gentianaceae. Macronutrient content is not applicable to the bark preparations used medicinally, and bioavailability of any constituent has not been studied in human subjects.
How It Works
Mechanism of Action
The presumed primary bioactive constituents of Fagraea berteroana are iridoid glycosides and secoiridoids, compound classes that are characteristic of the Gentianaceae family to which this species belongs; these molecules inhibit IκB kinase (IKK) phosphorylation, thereby preventing NF-κB p65 nuclear translocation and downstream transcription of pro-inflammatory mediators including COX-2, TNF-α, and IL-1β. Tannins and condensed polyphenols present in the bark act through protein precipitation and membrane disruption mechanisms that confer antimicrobial activity and astringent wound-healing properties. Flavonoid constituents likely contribute free-radical scavenging activity through electron donation to superoxide and hydroxyl radicals, reducing oxidative stress in inflamed tissue. All proposed mechanisms are extrapolated from pharmacological data on closely related Gentianaceae genera including Gentiana, Swertia, and Canscora, and have not yet been directly confirmed through in vitro or in vivo studies of Fagraea berteroana itself.
Clinical Evidence
No formal clinical trials have been conducted on Fagraea berteroana or any standardized extract derived from it, and therefore no quantified effect sizes, confidence intervals, or patient-level outcome data exist in the published literature. The entire clinical evidence base rests on ethnobotanical documentation of traditional use among Pacific Island communities, particularly in Tonga, where topical bark applications are described for wound management. In the absence of Phase I through Phase III trial data, it is not possible to establish efficacious doses, define therapeutic windows, or confirm superiority over placebo for any indication. Researchers with interest in Pacific Island ethnopharmacology have identified Fagraea berteroana as a candidate for phytochemical profiling and preclinical efficacy studies, but this work has not been completed and published in peer-reviewed form.
Safety & Interactions
The safety profile of Fagraea berteroana has not been evaluated in formal toxicological studies, and no adverse event data from clinical use or case reports is available in the indexed scientific literature, making it impossible to define safe dose ranges or maximum tolerated doses. Given the presence of bitter iridoid and possible alkaloid compounds common to Gentianaceae, internal use at high doses may cause gastrointestinal irritation, nausea, or vomiting, as observed with related family members such as Gentiana species. Potential drug interactions have not been investigated; theoretical caution is warranted with anticoagulants, antiplatelet agents, and hepatically metabolized drugs (CYP450 substrates) given the tannin and polyphenol content that may affect drug absorption or metabolism. Use during pregnancy and lactation cannot be considered safe given the complete absence of safety data, and use in children should be avoided outside culturally supervised traditional contexts; individuals with known hypersensitivity to Gentianaceae family plants should exercise particular caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Fagraea berteroanaLupe (Tongan)Pua lupe (Samoan)Gentianaceae tropical treePacific fig-tree jasmine
Frequently Asked Questions
What is lupe used for in traditional Tongan medicine?
In Tongan traditional medicine, lupe refers to Fagraea berteroana, a tree whose bark is scraped, boiled, or pounded into poultices and applied topically to wounds, skin infections, and ulcers. Healers value the bark for its perceived antimicrobial and wound-closing properties, which are consistent with the astringent tannins and iridoid compounds expected in members of the Gentianaceae family to which this tree belongs.
What bioactive compounds are found in Fagraea berteroana?
Direct phytochemical analysis of Fagraea berteroana is very limited in the published literature, but based on the chemistry of closely related Gentianaceae genera, the bark is expected to contain iridoid glycosides, secoiridoids, condensed tannins, flavonoid glycosides, and triterpenoids such as oleanolic acid. These compound classes are responsible for the bitter taste, astringency, and antimicrobial and anti-inflammatory activities observed in related species, though specific compound identities and concentrations in F. berteroana await formal phytochemical characterization.
Is there scientific evidence supporting lupe for wound healing?
Currently, no controlled clinical trials or peer-reviewed laboratory pharmacology studies have been published specifically on Fagraea berteroana for wound healing or any other indication. Evidence is limited to ethnobotanical surveys, most notably Whistler's 1992 documentation of Pacific Island medicinal plants, which record the bark's topical use by Tongan healers. The wound-healing application is plausible based on the chemistry of related Gentianaceae species, but direct scientific validation is still needed.
Is Fagraea berteroana safe to consume or apply topically?
No formal toxicological studies have been conducted on Fagraea berteroana, so a definitive safety profile cannot be established. Topical traditional use under the guidance of experienced Pacific Island healers has a long cultural history without widely reported adverse effects, but internal consumption carries unknown risks due to potential iridoid bitterness, tannin-mediated gastrointestinal irritation, and uninvestigated drug interactions. Pregnancy, lactation, and use in children represent populations where caution is especially warranted given the absence of safety data.
How does lupe relate to other plants in the Gentianaceae family?
Fagraea berteroana is classified within Gentianaceae, a family well-known for producing bitter secoiridoid glycosides such as gentiopicroside, amarogentin, and swertiamarin, which are responsible for the medicinal reputation of plants like gentian root (Gentiana lutea) and chiretta (Swertia chirata). These compounds share anti-inflammatory, antimicrobial, and hepatoprotective properties across the family, making the Gentianaceae chemical framework a useful lens for predicting and investigating the likely bioactivity of lupe, even in the absence of species-specific studies. Researchers studying Pacific Island ethnopharmacology have recognized Fagraea as an under-investigated genus with high phytochemical potential relative to its family affiliations.
What is the most effective form of lupe (Fagraea berteroana) for wound healing — bark decoction, extract, or topical preparation?
Topical bark preparations and decoctions have the strongest traditional use evidence for wound healing in Tongan ethnomedicine, as they allow direct contact between astringent tannins and iridoids with damaged tissue. While standardized extracts may offer consistent bioactive compound levels, the water-soluble nature of many active compounds in Fagraea berteroana bark makes decoctions and poultices potentially more bioavailable for topical application than alcohol-based extracts. Clinical studies directly comparing these preparation methods are limited, so traditional preparation methods remain the most evidence-supported approach.
Who should avoid using lupe, and are there specific populations for whom Fagraea berteroana is contraindicated?
While safety data is limited, the high tannin content of lupe bark suggests that pregnant and nursing women should avoid internal consumption, as tannins may affect nutrient absorption and fetal development. Individuals with tannin-sensitive digestive systems or those taking medications that require optimal absorption should consult a healthcare provider before internal use. Topical application on open wounds may be safer for broader populations, though individuals with known allergies to Gentianaceae family plants should exercise caution.
Does lupe (Fagraea berteroana) contain the same antimicrobial iridoids as other medicinal plants in the Gentianaceae family, and how do they compare?
While related Fagraea and Gentianaceae species contain secoiridoids such as gentiopicroside and sweroside with documented antimicrobial properties, Fagraea berteroana's specific iridoid profile has not been comprehensively characterized in published research. The presence of these bioactive compounds in lupe suggests comparable antimicrobial potential to well-studied Gentianaceae members like gentian root, though the relative potency and iridoid concentrations remain unknown. Further phytochemical analysis is needed to establish whether lupe's antimicrobial efficacy matches or differs from other family members.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w lupe-fagraea-berteroana curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
